Study of the Anti-Inflammatory Effects of Colgate Total® During an Experimental Gingivitis Model

NCT ID: NCT01799226

Last Updated: 2016-01-13

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-03-31

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the anti-inflammatory effects of Colgate Total® during an experimental gingivitis model developed by Löe et al. Half of the participants will use Colgate Total® (which contains triclosan), while the other half will use a toothpaste which does not contain triclosan as the control.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This will be a double-blind. Subjects will be randomly assigned to the test or control dentifrice arm. Enrolled subjects will also be randomly assigned to either right or left side mandibular stent.

During the induction phase (i.e., day 0 to day 21), participants are instructed to refrain from all hygiene procedures in the stent area. During this time period, participants evenly distributed 2mL of their assigned dentifrice into their stent, allowing it to come into contact with the areas of experimental gingivitis for two minutes twice daily while traditional tooth brushing was performed in the non-stent areas. Clinical measures, saliva, gingival crevicular fluid and plaque samples will be collected at days 0, 14, 21, and 35 study visits. A randomization chart will be used to identify which two sites (teeth and tooth surface) will be used at the specific study visit for collection of gingival crevicular fluid(GCF) and plaque.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gingivitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Toothpaste without Triclosan

This arm will use a toothpaste that does not contain triclosan

Group Type ACTIVE_COMPARATOR

Toothpaste without triclosan

Intervention Type OTHER

this intervention will use a toothpaste without triclosan

Triclosan

This arm will use colgate total which contains triclosan

Group Type EXPERIMENTAL

Triclosan

Intervention Type OTHER

this intervention will use Colgate Total which contains triclosan

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Toothpaste without triclosan

this intervention will use a toothpaste without triclosan

Intervention Type OTHER

Triclosan

this intervention will use Colgate Total which contains triclosan

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Colgate total toothpaste

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Race - all
* Gender - female or male
* Age - 18 to 40 years old
* Dentition - minimum of 20 permanent teeth
* Probing Pocket Depth of 1-4mm in all sites
* Mean Clinical Attachment Levels of 2mm on all teeth
* Bleeding Upon Probing of greater than 30% at Day -14 Study Visit
* Consent Form - read, understood, and signed
* Study Procedures - willing to follow all study procedures
* BOP less than 10% at the second assessment visit will be exited from the
* study

Exclusion Criteria

* Medical History - a history of alcoholism or drug abuse
* Diseases of the immune system
* Medical condition that may affect outcome (neurologic or psychiatric disorders, systemic infection
* Medications - chronic medications known to affect the periodontal status (calcium antagonists anticonvulsives, immunosuppressives, anti-inflammatory medications, phenytoin, Depo-Provera contraceptive injection users
* New oral contraceptives users within 3 months of baseline or are planning on starting oral contraceptives during the study
* Hypersensitivity - previous known reaction to or oral allergy to any ingredient in the study toothpaste
* Antibiotics - antibiotic therapy within 3 months of baseline visit
* antibiotic therapy needed for infective endocarditis prophylaxis or total joint replacement
* Use of antiseptics - homecare regime using products to control dental plaque formation within 30 days prior to baseline visit
* Smoking - current smokers, smokers who quit smoking less than one year ago, or a pack-year history of more than or equal to 10 (pack-years will be calculated by multiplying the number of years smoked by the average number of cigarette packs smoked per day)
* Continine - positive urine analysis results
* Current Dental Treatment - orthodontic or periodontal treatment
* Untreated Dental Treatment - untreated carious lesions
* Defective restorations which could exacerbate during a period of oral hygiene abstinence
* Pregnant or women breast-feeding
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Michigan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Janet Kinney

Assistant Professor of Dentistry, Director of Dental Hygiene Program

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Janet Kinney, MS

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Michigan Center for Oral Health Research

Ann Arbor, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Pancer BA, Kott D, Sugai JV, Panagakos FS, Braun TM, Teles RP, Giannobile WV, Kinney JS. Effects of triclosan on host response and microbial biomarkers during experimental gingivitis. J Clin Periodontol. 2016 May;43(5):435-44. doi: 10.1111/jcpe.12519. Epub 2016 Apr 6.

Reference Type DERIVED
PMID: 26820239 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HUM00055445

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Study of Experimental Mouthwashes
NCT05121909 COMPLETED PHASE4